MicrobeWorld App

appsquarebannerad200x200

Microbes After Hours

WaterSupplyYouTubeFrame

Click for more "Microbes After Hours" videos

Join MicrobeWorld

Subscribe via Email

subscribe

Featured Image

Featured Video

Ebola Virus explained

Supporters

ASM House 200X200

High Dose Therapy for Influenza Drug - ICAAC 2013














Critically ill patients with the pandemic H1N1 influenza who received triple the standard dose of the influenza drug oseltamivir were 7 times more likely to completely clear the virus from their system in 5 days than those who received the standard dose. This discussion addresses the healthcare implications of these findings, including a rationale for high dose therapy of sensitive strains of influenza.

Host:
Michael Schmidt, Medical Univ. of South Carolina, Charleston, SC

Gueat:
Anand Kumar, Hlth. Sci. Ctr., Winnipeg, MB, Canada
 
 

Comments (0)

Collections (1)

 

American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use